US Stock MarketDetailed Quotes
CPIX Cumberland Pharmaceuticals
- 1.390
- 0.0000.00%
Trading Aug 15 16:00 ET
19.59MMarket Cap-1930P/E (TTM)
0.000High0.000Low231Volume1.380Open1.390Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)14.10MShares2.35952wk High0.74P/B11.03MFloat Cap1.38052wk Low--Dividend TTM7.94MShs Float17.750Historical High--Div YieldTTM0.00%Amplitude1.380Historical Low0.000Avg Price1Lot Size
Cumberland Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.55%9.85M | -7.88%8.5M | -5.85%39.55M | 2.51%9.35M | -11.63%10.09M | 5.73%10.89M | -17.45%9.22M | 16.75%42.01M | 9.66%9.12M | 41.38%11.41M |
| Operating revenue | -9.55%9.85M | -7.88%8.5M | -7.79%37.51M | -6.16%7.31M | -11.63%10.09M | 5.73%10.89M | -17.45%9.22M | 16.08%40.68M | 5.61%7.79M | 41.38%11.41M |
| Cost of revenue | 12.50%1.71M | 26.02%1.58M | -33.47%6.07M | -42.27%1.53M | -20.63%1.77M | -25.15%1.52M | -43.48%1.25M | 3.49%9.12M | -20.30%2.65M | 67.50%2.22M |
| Gross profit | -13.13%8.14M | -13.19%6.92M | 1.80%33.49M | 20.85%7.82M | -9.45%8.32M | 13.32%9.37M | -11.03%7.97M | 21.04%32.89M | 29.61%6.47M | 36.24%9.19M |
| Operating expense | -1.93%9.16M | -7.52%8.79M | 11.51%43.04M | 60.01%14M | 7.49%10.19M | -7.60%9.35M | -7.30%9.51M | 10.75%38.6M | -6.39%8.75M | 14.07%9.48M |
| Selling and administrative expenses | -0.52%7.01M | -3.75%6.52M | 8.43%29.1M | 19.04%8.2M | 12.91%7.09M | 4.16%7.04M | -2.03%6.78M | 8.25%26.84M | 2.51%6.89M | 7.47%6.28M |
| -Selling and marketing expense | -9.07%4.25M | -2.87%4.15M | 10.75%18.45M | 40.83%4.76M | 15.39%4.74M | 2.53%4.67M | -7.31%4.28M | 10.96%16.66M | 2.22%3.38M | 8.16%4.11M |
| -General and administrative expense | 16.34%2.76M | -5.25%2.37M | 4.63%10.65M | -1.95%3.44M | 8.21%2.34M | 7.53%2.37M | 8.54%2.5M | 4.09%10.18M | 2.79%3.51M | 6.19%2.17M |
| Research and development costs | -7.50%1.06M | -22.77%1.16M | -12.78%5.83M | -10.04%1.26M | 12.28%1.92M | -37.21%1.15M | -14.07%1.5M | 17.67%6.69M | -12.83%1.41M | 17.91%1.71M |
| Depreciation amortization depletion | -5.04%1.1M | -9.71%1.11M | 59.90%8.1M | 890.60%4.54M | -20.94%1.18M | -24.27%1.16M | -22.79%1.23M | 15.92%5.07M | -54.95%458.22K | 46.60%1.49M |
| -Depreciation and amortization | -5.04%1.1M | -9.71%1.11M | 59.90%8.1M | 890.60%4.54M | -20.94%1.18M | -24.27%1.16M | -22.79%1.23M | 15.92%5.07M | -54.95%458.22K | 46.60%1.49M |
| Operating profit | -4,591.40%-1.03M | -22.04%-1.87M | -67.48%-9.55M | -171.28%-6.18M | -546.81%-1.87M | 101.24%22.86K | -18.55%-1.53M | 25.69%-5.7M | 47.68%-2.28M | 81.54%-288.59K |
| Net non-operating interest income expense | 52.42%-64.51K | 84.00%-21.78K | 21.86%-381.01K | 26.89%-97.79K | 91.01%-11.48K | -10.62%-135.57K | -31.52%-136.16K | -577.68%-487.59K | -535.02%-133.76K | -911.63%-127.74K |
| Non-operating interest income | 8.38%61.84K | 92.76%96.75K | 191.50%286.85K | 77.26%81K | 356.45%98.6K | 278.74%57.06K | 212.89%50.19K | 277.31%98.41K | 585.10%45.7K | 192.16%21.6K |
| Non-operating interest expense | -34.41%126.35K | -36.40%118.53K | 13.97%667.86K | -0.37%178.79K | -26.29%110.08K | 39.97%192.64K | 55.85%186.35K | 497.76%586K | 547.06%179.46K | 645.92%149.34K |
| Other net income (expense) | 497.17%3.65M | 0 | 821.8K | 60.60%981.81K | 1.85M | -72.05%611.33K | 0 | |||
| Special income (charges) | ---- | ---- | 34.43%821.8K | --0 | --821.8K | ---- | ---- | --611.33K | --0 | --0 |
| -Less:Other special charges | ---- | ---- | -34.43%-821.8K | --0 | ---821.8K | ---- | ---- | ---611.33K | --0 | ---- |
| Other non- operating income (expenses) | ---- | ---- | --2.83M | --0 | ---- | --981.81K | --1.85M | ---- | ---- | ---- |
| Income before tax | -225.56%-1.09M | -1,155.12%-1.89M | -12.61%-6.28M | -160.29%-6.28M | -153.71%-1.06M | 164.01%869.09K | 112.84%179.22K | -0.34%-5.58M | 44.88%-2.41M | 73.58%-416.33K |
| Income tax | 64.96%11.44K | 64.92%11.44K | -33.52%45.77K | -48.17%24.96K | 0.55%6.94K | 0.54%6.94K | 0.55%6.94K | 97.33%68.85K | 284.71%48.15K | -7.48%6.9K |
| Net income | -227.89%-1.1M | -1,204.25%-1.9M | -12.05%-6.33M | -156.21%-6.3M | -151.22%-1.06M | 163.18%862.15K | 112.28%172.29K | -56.82%-5.65M | 36.67%-2.46M | 61.05%-423.23K |
| Net income continuous Operations | -227.89%-1.1M | -1,204.25%-1.9M | -12.05%-6.33M | -156.21%-6.3M | -151.22%-1.06M | 163.18%862.15K | 112.28%172.29K | -0.95%-5.65M | 43.94%-2.46M | 73.27%-423.23K |
| Minority interest income | -69.47%-17.03K | 320.08%43.79K | 35.53%-51.45K | 60.07%-7.58K | 4.57%-13.92K | 65.41%-10.05K | -15.82%-19.9K | 16.19%-79.8K | 48.07%-18.99K | 53.57%-14.59K |
| Net income attributable to the parent company | -224.47%-1.09M | -1,112.71%-1.95M | -12.73%-6.28M | -157.89%-6.29M | -156.78%-1.05M | 165.30%872.2K | 113.87%192.18K | -58.81%-5.57M | 36.57%-2.44M | 61.28%-408.64K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -224.47%-1.09M | -1,112.71%-1.95M | -12.73%-6.28M | -157.89%-6.29M | -156.78%-1.05M | 165.30%872.2K | 113.87%192.18K | -58.81%-5.57M | 36.57%-2.44M | 61.28%-408.64K |
| Basic earnings per share | -233.33%-0.08 | -1,500.00%-0.14 | -15.79%-0.44 | -158.82%-0.44 | -133.33%-0.07 | 166.67%0.06 | 111.11%0.01 | -58.33%-0.38 | 34.62%-0.17 | 57.14%-0.03 |
| Diluted earnings per share | -233.33%-0.08 | -1,500.00%-0.14 | -15.79%-0.44 | -158.82%-0.44 | -133.33%-0.07 | 166.67%0.06 | 111.11%0.01 | -58.33%-0.38 | 34.62%-0.17 | 57.14%-0.03 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
